Badgley, Phelps & Bell’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$946K Sell
11,627
-13
-0.1% -$1.06K 0.04% 135
2021
Q1
$918K Sell
11,640
-401
-3% -$31.4K 0.04% 134
2020
Q4
$1.03M Sell
12,041
-364
-3% -$30.1K 0.04% 128
2020
Q3
$957K Buy
12,405
+194
+2% +$14.8K 0.05% 128
2020
Q2
$895K Sell
12,211
-116
-0.9% -$8.24K 0.05% 125
2020
Q1
$818K Sell
12,327
-877
-7% -$61.9K 0.05% 116
2019
Q4
$909K Buy
13,204
+208
+2% +$14.2K 0.05% 122
2019
Q3
$955K Hold
12,996
0.05% 118
2019
Q2
$931K Sell
12,996
-1,592
-11% -$113K 0.05% 121
2019
Q1
$1M Sell
14,588
-98,104
-87% -$6.34M 0.06% 119
2018
Q4
$6.71M Sell
112,692
-19,123
-15% -$1.2M 0.48% 79
2018
Q3
$8.82M Buy
131,815
+4,214
+3% +$281K 0.54% 78
2018
Q2
$8.27M Buy
127,601
+2,842
+2% +$186K 0.54% 80
2018
Q1
$8.94M Buy
124,759
+8,717
+8% +$627K 0.6% 79
2017
Q4
$8.76M Buy
116,042
+8,868
+8% +$648K 0.6% 77
2017
Q3
$7.81M Sell
107,174
-2,549
-2% -$184K 0.58% 82
2017
Q2
$8.13M Sell
109,723
-2,352
-2% -$175K 0.63% 76
2017
Q1
$8.2M Buy
112,075
+3,092
+3% +$216K 0.66% 73
2016
Q4
$7.13M Sell
108,983
-2,482
-2% -$170K 0.62% 79
2016
Q3
$8.26M Buy
111,465
+1,592
+1% +$118K 0.73% 58
2016
Q2
$8.04M Buy
109,873
+596
+0.5% +$42.4K 0.73% 54
2016
Q1
$7.72M Buy
109,277
+1,309
+1% +$87.1K 0.73% 53
2015
Q4
$7.19M Buy
107,968
+547
+0.5% +$36.4K 0.71% 62
2015
Q3
$6.82M Sell
107,421
-2,226
-2% -$145K 0.71% 62
2015
Q2
$7.17M Sell
109,647
-1,120
-1% -$76K 0.7% 65
2015
Q1
$7.68M Sell
110,767
-1,047
-0.9% -$72.4K 0.76% 60
2014
Q4
$7.74M Sell
111,814
-827
-0.7% -$55.9K 0.76% 66
2014
Q3
$7.35M Buy
112,641
+272
+0.2% +$17.9K 0.73% 67
2014
Q2
$7.66M Sell
112,369
-1,112
-1% -$74.5K 0.76% 59
2014
Q1
$7.36M Buy
113,481
+372
+0.3% +$23.4K 0.76% 58
2013
Q4
$7.38M Buy
113,109
+105,587
+1,404% +$6.76M 0.78% 60
2013
Q3
$446K Hold
7,522
0.05% 114
2013
Q2
$431K Buy
+7,522
New +$446K 0.05% 117

Other funds holding CL

Badgley, Phelps & Bell's CL Position: Q2 2021 in Review

Badgley, Phelps & Bell reduced its Colgate-Palmolive (CL) stake by 0.11% in Q2 2021, selling an estimated $1.06K and leaving 11,627 shares worth $946K. The position accounts for 0.04% of the portfolio, ranked #135.

Badgley, Phelps & Bell first reported a position in CL in Q2 2013 and has held it in 33 quarters since. The position peaked at $8.94M in Q1 2018. 1,634 funds tracked by Wall St. Rank hold CL as of Q2 2021.

  • Badgley, Phelps & Bell held 11,627 shares of Colgate-Palmolive worth $946K as of Q2 2021.
  • Badgley, Phelps & Bell sold 13 Colgate-Palmolive shares in Q2 2021, an estimated $1.06K.
  • Colgate-Palmolive made up 0.04% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #135 holding.
  • Badgley, Phelps & Bell first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 33 quarters since.
  • Badgley, Phelps & Bell's Colgate-Palmolive position peaked at $8.94M in Q1 2018.
  • 1,634 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.